ACRE advice: camelina trial
The advice of the Advisory Committee on Releases to the Environment on the release of genetically modified camelina.
Documents
Details
These documents are the advice of the Advisory Committee on Releases to the Environment (ACRE) to government on an application from Rothamsted Research to carry out a trial of Camelina sativa, which has been genetically modified to produce omega-3 fatty acids in its seed oil.
The committee advised that the risks to human health and the environment from this trial are extremely low.
Updates to this page
Last updated 9 May 2019 + show all updates
-
Added the advice on an application for a trial of GM camelina (19/R08/01).
-
Added ACRE advice on GM Camelina (16/R8/01).
-
First published.